November 2009 — MacroGenics, Inc., located in Rockville, Maryland, has subscribed to R&D Logic software services to manage world-wide corporate planning and tracking,budgeting and forecasting, and financial reporting. MacroGenics'mission is to discover, develop and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases.

November 2009 — Facet Biotech, located in Redwood City, California, has subscribed to R&D Time software services to manage corporate budgeting and forecasting, time collection, and project FTE reporting. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc. Combining expertise in antibody engineering with a disciplined, biology-driven research approach, Facet Biotech is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs.

October 2009 — Inviragen, Inc.located in Fort Collins, Colorado, has subscribed to R&D Time software services to manage world-wide time collection and grant reporting. Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide.

June 2009 — KaloBios Pharmaceuticals, located in South San Francisco, California, has subscribed to R&D Time software services to manage corporate time collection and project FTE reporting.KaloBios uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics.

May 2009 — Medivation, Inc., located in San Francisco, California, has subscribed to R&D Logic software services for planning and tracking expenses and resources at the corporate and project portfolio levels as well as for collecting and tracking R&D project time to collaborators and to internal management. Medivation is is a biopharmaceutical company with small molecule drugs in clinical development to treat three large, unmet medical needs.

April 2009 — Portola Pharmaceuticals located in South San Francisco, California, has subscribed to R&D Time software service to manage all corporate time collection, financial reporting, and project FTE reporting. Portola is discovering and developing novel therapeutics to meet patient needs in cardiovascular, inflammation, and oncology indications.

April 2009 — Nevro Corporation, located in Palo Alto, California, has subscribed to R&D Manage software service for planning and tracking expenses and resources at the corporate and project portfolio levels. Nevro is a medical device company developing novel neuromodulation therapies for multiple indications.

February 2009 — Portola Pharmaceuticals located in South San Francisco, California, has subscribed to R&D Time software service to manage all corporate time collection, financial reporting, and project FTE reporting. Portola is discovering and developing novel therapeutics to meet patient needs in cardiovascular, inflammation, and oncology indications.